Single nucleotide polymorphism rs5029937 in TNFAIP3 gene is correlated with risk of rheumatoid arthritis.
Bahram PakzadFarzaneh YousefisadrHadi KarimzadehMaryam MousaviElham NoormohamadiRasoul SalehiPublished in: Medical journal of the Islamic Republic of Iran (2021)
Background: Rheumatoid arthritis (RA) is a progressive and common autoimmune disease with multifactorial etiology. Several pieces of research show that genetic factors play a major role in the incidence of RA. Several genome-wide association studies (GWAS) have identified the tumor necrosis factor alpha inducible protein 3 (TNFAIP3) genes as one of the candidate loci. The TNFAIP3 gene encoding ubiquitin-editing protein A20 witch restricts B cell survival and prevents autoimmunity. Previous studies have indicated that single nucleotide polymorphisms (SNPs) in the TNFAIP3 gene are correlated with several autoimmune disorders. In the present study, we assessed the possible association between SNP rs5029937 (intronic variant) in the TNFAIP3 gene with RA risk in the Iranian population. Methods: A case-control study using 50 RA patients and 50 control subjects was undertaken to evaluate rs5029937 (G>T) genotypes using real-time PCR high resolution melting method (HRM). The SPSS22 was used for statistical analyses and the significance level was set at P<0.05. Results: Logistic regression analysis demonstrates that homozygous TT + heterozygous TG genotypes compared with GG genotype increase the risk of RA (TT+TG vs GG; P= 0.004, OR= 3.46; 95%CI [1.492-8.075]). Also, individuals with allele T were more frequently affected with RA than subjects with G allele (T vs G; P= 0.004, OR= 2.61; 95%CI [1.382-4.919]). Conclusion: Our findings propose a substantial correlation between rs5029937 (G>T) polymorphism and RA risk in Iranian population.
Keyphrases
- rheumatoid arthritis
- genome wide
- disease activity
- case control
- copy number
- ankylosing spondylitis
- dna methylation
- high resolution
- genome wide association
- genome wide identification
- interstitial lung disease
- multiple sclerosis
- end stage renal disease
- systemic lupus erythematosus
- newly diagnosed
- chronic kidney disease
- crispr cas
- real time pcr
- risk factors
- systemic sclerosis
- ejection fraction
- genome wide analysis
- gene expression
- peritoneal dialysis
- small molecule
- patient reported outcomes